triptolide has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Huo, Y; Liu, ZP; Wang, KX | 1 |
| Huang, J; Lu, DF; Wu, H; Yuan, X; Zhang, L | 1 |
2 other study(ies) available for triptolide and Coronary Restenosis
| Article | Year |
|---|---|
Stent-based delivery of triptolide reduces neointimal formation in rabbit iliac arteries.
Topics: Animals; Coronary Restenosis; Diterpenes; Epoxy Compounds; Iliac Artery; Male; Phenanthrenes; Rabbits; Stents; Tunica Intima | 2005 |
[Triptolide-eluting stent prevents porcine coronary artery in-stent restenosis by affecting PCNA and P27(kip1) expression].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Coronary Restenosis; Coronary Vessels; Cyclin-Dependent Kinase Inhibitor p27; Diterpenes; Drug-Eluting Stents; Epoxy Compounds; Immunohistochemistry; Male; Phenanthrenes; Proliferating Cell Nuclear Antigen; Random Allocation; Swine; Time Factors; Tunica Intima | 2007 |